IL6 and neoplasm: It has been reported that fucoidan can be used as an adjuvant by inducing the up-regulation of CD40, CD80 and CD86 expression and production of interleukin-6 (IL-6), IL-12 and tumor necrosis factor-α (TNF-α) in spleen cDCs, which may have an effect on the development of tumor vaccines.